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Abstract
Background: Leptospira interrogans is a spirochaete responsible for leptospirosis in mammals. The molecular
mechanisms of the Leptospira virulence remain mostly unknown. Recently, it has been demonstrated that
L. interrogans ClpB (ClpBLi) is essential for bacterial survival under stressful conditions and also during infection.
The aim of this study was to provide further insight into the role of ClpB in L. interrogans and answer the
question whether ClpBLi as a potential virulence factor may be a target of the humoral immune response
during leptospiral infections in mammals.
Results: ClpBLi consists of 860 amino acid residues with a predicted molecular mass of 96.3 kDa and shows
multi-domain organization similar to that of the well-characterized ClpB from Escherichia coli. The amino acid
sequence identity between ClpBLi and E. coli ClpB is 52 %. The coding sequence of the clpBLi gene was cloned
and expressed in E. coli BL21(DE3) strain. Immunoreactivity of the recombinant ClpBLi protein was assessed with
the sera collected from Leptospira-infected animals and uninfected healthy controls. Western blotting and ELISA
analysis demonstrated that ClpBLi activates the host immune system, as evidenced by an increased level of
antibodies against ClpBLi in the sera from infected animals, as compared to the control group. Additionally,
ClpBLi was found in kidney tissues of Leptospira-infected hamsters.
Conclusions: ClpBLi is both synthesized and immunogenic during the infectious process, further supporting its
involvement in the pathogenicity of Leptospira. In addition, the immunological properties of ClpBLi point to its
potential value as a diagnostic antigen for the detection of leptospirosis.
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Background
Leptospira interrogans belongs to pathogenic spirochaetes
causing a serious disease in both humans and animals
known as leptospirosis that is considered the most wide-
spread zoonosis of worldwide importance [1]. The vectors
of this pathogen are mostly wild rodents and domestic an-
imals, which harbor the spirochetes in the proximal renal
tubules of the kidneys and chronically excrete the lepto-
spires with urine into the environment [2]. It is worth not-
ing that leptospirosis is also a serious economic problem,
because it causes abortions, stillbirths, infertility, failure to
thrive, reduced milk production, and death in domestic
animals such as cows, pigs, sheep, goats, horses and dogs
[3–6]. In humans the disease varies from an asymptomatic
flu-like illness to an acute life-threatening infection. Des-
pite its severity and global importance, the molecular
mechanisms of leptospiral pathogenesis remain largely un-
known [1]. To date, only a few proteins have been identi-
fied as potential virulence factors in Leptospira. Among
them, there is the chaperone ClpB, a member the Hsp100/
Clp subfamily of the AAA+ ATPases that reactivates
stress-aggregated proteins in cooperation with the DnaK
system [7]. Recently, ClpB from L. interrogans (ClpBLi) has
been shown to be essential for bacterial survival under
stressful conditions (nutrient restriction, oxidative and
heat stresses) and also for the pathogen’s virulence [8].
The involvement of ClpB in the response of L. interrogans
to oxidative stress suggests that this chaperone may be
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one of key mediators of stress resistance, which is a pre-
requisite for Leptospira pathogenesis. The present study
provides further insight into the role of ClpBLi during the
infectious process. It is known that heat shock proteins
(Hsps) play important roles during bacterial infections.
They help pathogens to overcome stressful conditions to
which they are exposed within the host cells, and represent
major targets of the host’s immune system. Taking into ac-
count the fact that the chaperone ClpB from some patho-
genic bacteria, Francisella tularensis and Mycoplasma
pneumoniae, has been shown to be immunoreactive [9, 10],
we decided to investigate an immunogenic potential of
ClpBLi, which could point to this chaperone’s role in the
pathogenicity of Leptospira and may translate into diagnos-
tic applications.
Methods
Serum samples
We studied archived serum samples from rabbits and
cattle. Rabbit antisera (n = 8) against L. interrogans sero-
vars: Icterohaemorrhagiae, Hardjo, and Canicola, and L.
borgpetersenii serovars: Hardjo, Javanica, were prepared
as described by [11]. Polyclonal rabbit antiserum pre-
pared against the L. interrogans ClpB (residues 158–334;
anti-ClpBLi158–334 serum) [8] and provided by M. Picar-
deau was used as a positive control and the pre-immune
serum was used as a negative control. Bovine sera were
collected from cattle (n = 10) experimentally infected with
L. borgpetersenii serovar Hardjo via conjunctival instilla-
tion of 1 x 106 bacteria. Blood samples were collected
28 days after the challenge and in one case 210 days after
the challenge (this serum was used as a positive control
showing the highest OD in ELISA). Sera from uninfected
cattle (n = 8) and also a fetal bovine serum were used as
negative controls. To confirm the serological status of lep-
tospiral infection, the sera were subjected to the micro-
scopic agglutination test (MAT) [11, 12] and used at
dilutions 1:100 for Western blotting or 1:200 for ELISA.
Kidney homogenate preparation
For detection of ClpBLi in kidney tissues from Leptos-
pira-infected hamsters, the kidneys were macerated with
nine parts of a 1 % BSA diluent and inoculated into
Tween80/40/ LH semi-solid medium. Cultures were in-
cubated at 28–30 °C, for up to 10 weeks and examined
weekly by dark-field microscopy to detect the growth of
leptospires. The same macerated kidney tissues (20 μg
sample of homogenate) were used for Western-blotting
analysis. Total protein concentration in the homogenates
was determined by the method of Bradford [13].
Plasmid construction for protein overproduction
L. interrogans clpB gene (2583 bp) was amplified from
genomic DNA of L. interrogans by PCR using AccuTaq
LA polymerase MIX (Sigma) with the following primers:
CATATGAAATTAGATAAACTTACATCCAAATT with
the NdeI restriction site underlined, and AAGCTTT
TAAACTACAACAACTACC with the HindIII restric-
tion site underlined. DNA primers were synthesized by
Genomed S.A. (Warsaw, Poland). First, the PCR product
was cloned into pJET1.2 blunt vector (Fermentas), then
digested with NdeI, HindIII, and ligated with the line-
arized pET NdeI-HindIII vector. The sequence of the
resulting construct was confirmed by DNA sequencing
(Genomed S.A.). Leptospira genomic DNA was ex-
tracted with a QIAamp DNA Mini Kit (Qiagen).
DNA plasmid preparation and transformation of E.
coli cells were done according to [14].
Purification of the recombinant ClpBL
L. interrogans ClpB protein was overproduced in E. coli
BL21(DE3) strain (Novagen) and purified according to
the procedure similar to that used to obtain ClpB from
Ehrlichia chaffeensis [15]. Briefly, bacteria were grown at
37 °C to OD600 = 0.6 and then induced with 0.5 mM
IPTG for 2 h. Next, the cells were collected and suspended
in 50 mM Tris–HCl (pH 7.4), 300 mM NaCl, 20 mM
imidazole and 0.1 % Triton X-100, then disrupted by son-
ication in the presence of the protease inhibitor PMSF and
centrifuged to collect the soluble extract. Next, polyethyle-
neimine (PEI) was added to precipitate nucleic acids. After
centrifugation (20 000 g, 1 h), the supernatant was applied
to a Ni-NTA column (Qiagen) and the bound protein was
eluted with 50 mM Tris–HCl (pH 7.4), 300 mM NaCl,
and 0.1 % Triton X-100 and 250 mM imidazole. Fractions
containing a 6His-tagged ClpBLi (a calculated molecular
mass of 98 488.59 Da) were identified with SDS-PAGE
electrophoresis and Coomassie blue staining, then com-
bined and further purified by gel filtration on Superdex
200 (Sigma) equilibrated with 50 mM Tris–HCl (pH 7.5),
10 % glycerol, 1 mM EDTA and 1 mM DTT. The pooled
fractions containing ClpBLi were dialyzed against dialysis
buffer (50 mM Tris–HCl pH 7.5, 1 mM EDTA, 1 mM
DTT, 20 mM MgCl2, 200 mM KCl, 10 % glycerol) and
stored at −70 °C. The N-terminal histidine tag was re-
moved by proteolytic digestion using the Thrombin
Cleavage Capture Kit (Novagen) according to the man-
ufacturer’s protocol. The identity of the purified ClpBLi
was confirmed by a liquid chromatography-tandem
mass spectrometry (LC-MS/MS) analysis of tryptic pep-
tides obtained after trypsin cleavage of the protein, per-
formed at the MS LAB IBB PAN (Warsaw, Poland). The
equipment used was sponsored in part by the Centre for
Preclinical Research and Technology (CePT), a project
co-sponsored by European Regional Development Fund
and Innovative Economy, The National Cohesion Strategy
of Poland.
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SDS-PAGE and Western blotting analysis
To assess immune reactivity of ClpBLi, SDS-PAGE elec-
trophoresis was performed according to [16] using 10 %
polyacrylamide gels and Western blotting was performed
as described [17]. The blots were blocked with 0.1 %
Tween 20 in Tris-buffered saline (TBS) for 1 h at room
temperature and then incubated overnight at 4 °C with
anti-ClpBLi158–334 serum (1: 2000 dilution) [8] or polyclonal
A
B
Fig. 1 Proposed domain organization of ClpB from L. interrogans. a The diagram shows structural domains of the protein: N-terminal domain
(ND) with the double Clp_N motif, nucleotide binding domain 1 (NBD1), middle coiled-coil domain (MD) and nucleotide binding domain 2
(NBD2). Conserved ATPase motifs such as the Walker A (A), Walker B (B), sensor 1, sensor 2 (GAR) and the Arg fingers (R), coordinating ATP binding and
hydrolysis are also indicated. Conserved residues of these motifs are marked in bold. b Sequence alignment of ClpB from E. coli (BEc) and L. interrogans
(BLi). Domain boundaries are indicated below the amino acid sequence. The conserved motifs are shown in red. Identical and similar amino acid resides
are shaded in black and gray, ... respectively
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rabbit and bovine sera (1:100 dilution) against Leptospira
strains. After primary antibody incubation, the blots were
washed three times with TBS containing 0.05 % Tween 20
and incubated for 1 h at room temperature with the goat
anti-rabbit IgG horseradish peroxidase (HRP) conjugate
(Sigma) diluted 1: 3000 or the polyclonal rabbit anti-cow
Ig/HRP conjugate (DakoCytomation) diluted 1: 1000. The
blots were then washed three times as described above
and were developed using 3,3′-diaminobenzidine (Sigma),
and H2O2 as substrates.
ELISA procedure
ELISA (enzyme-linked immunosorbent assay), was per-
formed to analyze the immune response in animals experi-
mentally exposed to L. interrogans serovars. Costar 96 well
EIA/RIA polystyrene high-binding plates were coated with
100 μl of 0.625 μg/ml of the recombinant ClpBLi (a capture
antigen) resuspended in phosphate-buffered saline (PBS) by
incubation overnight at 4 °C. The plates were then washed
five times with PBST buffer (PBS containing 0.05 % Tween
20) and non-specific binding sites were blocked by incuba-
tion with 100 μl of 0.1 % Tween 20 in PBS buffer for 1 h at
room temperature. The wells were washed five times with
PBST buffer. Control and duplicate animal serum samples
were diluted 200-fold in PBST buffer and 50 μl of the di-
luted sera (in duplicate) were applied to each well and incu-
bated at 37 ° C for 1 h, followed by five rinses with PBST
buffer. Next, secondary HRP-conjugated anti-rabbit
(Abcam) (diluted 1:10 000) or anti-cow IgG (DakoCytoma-
tion) (diluted 1:2000) were added to each well and incu-
bated for 1 h at 37 °C. The plates were then washed five
times with PBS buffer and 3,3′,5,5′-tetramethylbenzidine
(TMB) (Sigma-Aldrich) was added to detect the antibodies.
The reaction was stopped after 10 min by the addition of
50 μl of 1 M H2SO4. The absorbance at 450 nm was mea-
sured using PerkinElmer Multimode Plate Reader (Enspire).
The assay was performed three times for each serum.
Data analysis
The statistical significance of differences between the
ELISA results obtained for sera collected from uninfected
and infected animals were determined using the Welch’s
adjusted one-way ANOVA followed by the post-hoc
Scheffe multiple comparison test. P < 0.05 was considered
statistically significant. Results of data analysis are pre-
sented in the graphs as the median values. All statistical
analyses were performed using STATISTICA PL program.
Results
Analysis of the amino-acid sequence of the molecular
chaperone ClpB from L. interrogans
The clpBLi gene encodes a protein of 860 amino acid
residues with a predicted molecular mass of 96325.2 Da.
Sequence alignment of ClpBLi (Fig. 1) revealed that this
protein shows a multi-domain organization similar to
that of the well-characterized ClpB from Escherichia
coli (ClpBEc). Thus, ClpBLi contains an N-terminal do-
main (ND1-145aa), two nucleotide binding domains
(NBD1161-342aa, NBD2560-768aa) and a middle coiled-coil
domain (MD393-527aa) (Fig. 1). Both NBDs, involved in
ATP binding and ATP hydrolysis, contain all character-
istic and conserved sequence mofits of AAA+ ATPases
(ATPases associated with a variety of cellular activities), i.e.
Walker A (GX4GKT/S), Walker B (Hy2DE) and sensor 1/2
motifs. Conserved arginine residues called Arg fingers are
also present in both NBD domains. Sequence alignment of
the ClpB sequences from bacteria L. interrogans and E. coli
using the Clustal software revealed that the total sequence
identity between them is only 52 %; 27.7 % within ND,
45.3 % within MD, 72 % within NBD1, and 65.7 % within
NBD2. Therefore, the most highly conserved are the NBD
domains and the main differences between L. interrogans
and E. coli ClpB are in the N-terminal domain and the
coiled-coil middle domain.
Expression of the clpBLi gene in E. coli cells and
purification of ClpBLi
To examine whether ClpBLi shows an immunogenic
potential, which could point to its participation in the
pathogenicity of Leptospira, we obtained a construct
expressing clpBLi (pET28clpBLi) and then overproduced
the recombinant ClpBLi as a 6-histidine-tagged protein
in E. coli B21(DE3) cells. As expected, the expression
of pET28clpBLi resulted in the ~100-kDa protein,
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Fig. 2 Purification of L. interrogans ClpB. a The Coomassie blue-stained
SDS-PAGE gel showing the lysates from E. coli cells transformed with the
recombinant plasmid expressing clpBLi (pET28clpBLi) without induction
(−) (lane 1) and induced with IPTG (+) (lane 2), and the representative
fractions obtained following the nickel resin (Ni-NTA, lane 3) and gel
filtration (GF, lane 4) purification of ClpBLi. The arrow indicates the
position of the 6His-tagged ClpBLi (~98.5 kDa). b The Coomassie
blue-stained SDS-PAGE gel showing ClpBLi digested with thrombin
(lane 1) and the 6His-tagged ClpBLi (lane 2). The positions of protein
size markers (M) (in kDa), PageRuler prestained Protein Ladder (Thermo
Scientific), are shown on the ... left
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Fig. 3 LC-MS/MS analysis of the purified ClpBLi. The amino acid sequence of ClpBLi is shown with the peptides detected by LC-MS/MS indicated in ... red
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M positive /negative/Hardjo/Icterohaemorrhagiae/Canicola/Hardjo/Hardjo/ Hardjo /Javanica
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Fig. 4 Immune reactivity of the recombinant ClpBLi with rabbit sera. a The purified ClpBLi protein (250 ng) was resolved by SDS-PAGE and
analyzed by Western blotting using: the antiserum against ClpBLi158–334 (a positive control), pre-immune control serum (a negative control), or
polyclonal rabbit antisera raised against: L. interrogans and L. borgpetersenii serovars as indicated in the figure. The positions of protein size
markers (M) (in kDa), PageRuler prestained Protein Ladder (Thermo Scientific), are shown on the left. The arrow indicates the position of ClpBLi.
(b) ELISA analysis of the recombinant ClpBLi protein as a capture antigen using all the above rabbit sera. The data were analyzed using Welch
adjusted one-way ANOVA. Symbols: (▫), the median value; (box), 25 %–75 % range around the median value; (whiskers), min-max range. (***)
denotes P < 0.001; ns, not statistically significant
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corresponding to ClpBLi that was soluble in E. coli
cells. The protein was purified from the soluble fraction
using two separation techniques: immobilized metal affin-
ity chromatography (IMAC) and gel filtration chromatog-
raphy (Fig. 2a). The identity of ClpBLi was confirmed with
an LC-MS/MS analysis (Fig. 3). The obtained peptide map
covered 88 % of the amino acid sequence of ClpBLi. In
addition, LC-MS/MS data indicated that the purified
ClpBLi was not contaminated with ClpB from the E. coli
host strain. The purified ClpBLi was subsequently digested
with thrombin to remove the N-terminal 6His-tag (Fig. 2b).
The post-cleavage N-terminal sequence of the recombinant
ClpBLi protein contains three additional amino acid
residues, namely GlySerHis, and in such form the pro-
tein was further characterized by Western blotting
analysis and ELISA assay.
Immunogenic capacity of ClpBLi
The immune reactivity of ClpBLi with serologically posi-
tive sera from rabbits and cattle experimentally infected
with two pathogenic Leptospira species (L. interrogans
and L. borgpetersenii) was tested by Western blotting
(Figs. 4a and 5a) and ELISA assay (Figs. 4b and 5b) and
compared to the sera from uninfected healthy controls.
We found that all the tested sera prepared from Leptospira-
infected animals, but not from the uninfected controls,
negative control
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fetal serum
infected animals
0,000
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0,188
0,287
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0,600
0,717
0,819
0,916
1,200
1,400
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Fig. 5 Immune reactivity of the recombinant ClpBLi with bovine sera. a The purified ClpBLi protein (250 ng) was resolved by SDS-PAGE and analyzed
by Western blotting using the antiserum against ClpBLi158–334 (a positive control; control +), polyclonal bovine antisera raised against: L. borgpetersenii
serovar Hardjo (Leptospira-infected cattle), and sera collected from uninfected cattle (healthy group; negative control). The positions of protein size
markers (M) (in kDa), PageRuler prestained Protein (Thermo Scientific), are shown on the left. The arrow indicates the position of ClpBLi (~100-kDa).
b ELISA analysis of the recombinant ClpBLi protein as a capture antigen using the above bovine sera. Fetal bovine serum was also used. The data were
analyzed using Welch adjusted one-way ANOVA. Symbols: (▫), the median value; (box), 25 %–75 % range around the median value, (whiskers),
min-max range. (***) denotes P <... 0.001
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strongly reacted with ClpBLi in Western blotting (Figs. 4a,
5a). The ELISA signals of the sera from infected animals
were also significantly higher than those of uninfected
animals (Figs. 4b, 5b; P < 0.001). These results show
that Leptospira infection induces production of anti-
ClpBLi antibodies in animal models. The cross-reactivity
between L. interrogans and L. borgpetersenii is not surpris-
ing due to ~95 % sequence similarity between ClpB from
those two species [8].
Detection of ClpBLi in Leptospira-infected animals
Additionally, we detected ClpBLi (96-kDa protein) in the
infected hamster kidney tissue (Fig. 6), from which lepto-
spires were isolated using standard culture method. No re-
activity of the 96-kDa protein with anti-ClpBLi158–334
serum was observed in the kidney homogenate obtained
from an uninfected hamster (Fig. 6, lane 4). The result
indicates that ClpBLi, is produced during an experimental
infection of animals.
In summary, our data indicate that the molecular
chaperone ClpBLi is immunogenic and detectable in ani-
mals infected with pathogenic Leptospira spp.
Discussion
Leptospires like many other pathogenic bacteria are ex-
posed to a significant stress during infection of host
cells, frequently resulting in protein misfolding and ag-
gregation. Despite being exposed to stressful conditions,
pathogens survive, overcome host defense mechanisms,
and cause the disease symptoms. The specific mechanisms
of the host invasion by leptospires are not well defined.
In particular, the molecular basis for virulence remains
unknown, due to the lack of genetic tools for the ma-
nipulation of Leptospira. The fact that ClpB is usually
up-regulated in pathogenic microorganisms [8, 15] sug-
gests that the disaggregase activity of ClpB may be es-
sential for their virulence. Moreover, the involvement
of ClpB in the response of L. interrogans to oxidative
stress [8] suggests that this chaperone may be one of
key mediators of stress resistance, which is a prerequisite
for Leptospira pathogenesis. The chaperone ClpB may
function either as a true virulence factor directly involved
in causing the disease or a virulence-associated protein
that can be essential for colonization of the host. Virulence
gene products are often immunogenic and responsible for
acquired immunity that protects against disease [18]. At
this point it should be also noted that molecular chaper-
ones despite their cytosolic localization are strongly im-
munogenic in a number of bacterial infections [19]. It has
been reported that some chaperones (e.g. GroEL) may be
associated with the outer membrane of the pathogenic
bacteria or exported from the bacterial cell after heat
shock [19]. Therefore, exposure of bacterial Hsps to the
host’s immune system is possible during infection. Indeed,
ClpB from some pathogens (i.e. Mycoplasma pneumoniae,
Francisella tularensis) is an immunoreactive protein [9,
10]. The total sequence identity between ClpB proteins
from these pathogens is only ~40 %. It is likely that ClpB
as an important mediator of resistance to oxidative stress
could be also a potential target for the host immune re-
sponse during leptospiral infections in mammals. There-
fore, we decided to investigate an immunogenic potential
of this chaperone in Leptospira. The use of the E. coli ex-
pression system allowed us to produce the recombinant
ClpBLi protein and to assess its immune reactivity with
sera collected from Leptospira-infected animals and the
uninfected healthy controls. Our results show that ClpB is
immunogenic during leptospiral infections because it was
recognized by sera collected from experimentally infected
animals (see Figs. 4 and 5). Thus, among the antibodies
raised against leptospiral proteins, there were specific anti-
bodies against ClpBLi. This is the first study where ClpB
from pathogenic Leptospira species was evaluated for its
ability to elicit immune responses in animals. Moreover,
our results suggest that ClpBLi could be considered as a
potential antigen candidate for a diagnostic test. We pos-
tulate that the presence of species-specific domains (e.g.
ND or MD, see Fig. 1) in the antigen could minimize a
cross-reactivity of antibodies with ClpB from different bac-
teria. Further prospective studies are needed to assess the
ClpBLi’s predictive value in leptospirosis diagnostics. In
addition, the presence of ClpBLi in the infected hamster
kidney tissues (see Fig. 6) demonstrates that the chaperone
is produced by pathogen during infection of the host fur-
ther confirming the involvement of ClpB in the pathogen-
icity of Leptospira.
Conclusions
Identification of Leptospira virulence factors and under-
standing their properties is crucial for uncovering the
diseases mechanisms. This study underlines the potential
1       2          3         4          5          6
100 kDa
infected         uninfected     infected
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Fig. 6 Detection of ClpBLi in hamster kidney tissues. The macerated
kidney tissues containing ~20 μg proteins were subjected to SDS-PAGE
followed by Western blotting with anti-ClpBLi158–334 serum. Lane 1,
purified ClpBLi (a positive control); lanes 2, 3, 5, 6, the kidney
homogenates from hamsters infected with L. interrogans serovar
Hardjo and euthanized 14 (lane 2) or 6 (lanes: 3,5,6) weeks post
infection; lane 4, the kidney homogenate from an uninfected hamster.
The arrow indicates the position of the 6His-tagged ClpBLi (~98.5 kDa).
The position of 100-kDa protein marker (PageRuler unstained Protein
Ladder; Thermo Scientific), is shown on the ... left
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importance of the chaperone ClpB in leptospiral infec-
tions. We believe that our data provide new information,
which may lead to a better understanding of the role of
ClpB and possibly other stress-response factors in the
life cycle of the pathogenic bacterium L. interrogans. It is
worth noting that since ClpB does not exist in animal
cells, it might become a promising target for novel ther-
apies against pathogenic Leptospira species. Further
studies are needed to determine the biological role of
ClpB during leptospiral infection in mammals and its
diagnostic or even immunoprotective potential. The re-
combinant ClpBLi produced in this work will help in fur-
ther biochemical characterization of this chaperone and
the analysis of its function in the pathogen.
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